Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06950788 · ClinicalTrials.gov registry record
Changes in Glucose Tolerance in Patients With Cirrhosis Peri-Liver Transplant
A clinical trial of Cirrhosis, Liver and Transplant; Failure, Liver, sponsored by University of Chicago.
- Recruiting
- Registry status
- 60
- Enrollment target
- 1
- Study location
NCT06950788: Recruiting study of Cirrhosis, Liver and Transplant; Failure, Liver, sponsored by University of Chicago.
NCT06950788 is a study of Cirrhosis, Liver and Transplant; Failure, Liver that is actively recruiting participants, run by University of Chicago. The registered enrollment target is 60 participants, below the 240-participant average among 34 other Cirrhosis, Liver trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06950788, a study of Cirrhosis, Liver and Transplant; Failure, Liver, is actively recruiting participants, sponsored by University of Chicago.
- RECRUITING
- Registry status
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this observational study is to establish risk factors for post-transplant in adult individuals with cirrhosis without diabetes undergoing liver transplant evaluation. The question being addressed is: can laboratory work, anthropometric tests, functional tests, imaging, and advanced measurements such as wrist actigraphy, continuous glucose monitoring, or oral glucose tolerance testing predict the development of diabetes after liver transplant? Participants will be asked to periodically participate in wearing a continuous glucose monitor and wrist actigraph and obtain an oral glucose tolerance test both before and after liver transplant.
Primary Outcome
Blood sugars above 200 mg/dL or requiring insulin therapy
Conditions Studied
Study Locations (1)
Illinois
- University of Chicago Medical Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2024-03-12 |
| Est. Completion | 2031-01 |
What NCT06950788 shows while recruiting
NCT06950788 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 240-participant average among 34 other Cirrhosis, Liver trials with a reported enrollment target (75% lower).
The record links to 4 conditions, with Cirrhosis, Liver appearing as the primary indexed condition, and to 0 interventions.
NCT06950788 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT06950788 about?
NCT06950788 is a clinical study titled "Changes in Glucose Tolerance in Patients With Cirrhosis Peri-Liver Transplant". The goal of this observational study is to establish risk factors for post-transplant in adult individuals with cirrhosis without diabetes undergoing liver transplant evaluation. The question being addressed is: can laboratory work, anthropometric tests, functional tests, imaging, and advanced meas...
What is the current status of trial NCT06950788?
This trial is currently recruiting. The enrollment target is 60 participants. The study started on 2024-03-12. Estimated completion is 2031-01.
What conditions does trial NCT06950788 study?
This clinical trial studies the following conditions: Cirrhosis, Liver, Transplant; Failure, Liver, Diabetes Mellitus Risk, Transplant-Related Disorder.
Who is sponsoring clinical trial NCT06950788?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06950788 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cirrhosis, Liver
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06950788's enrollment target sits among peer trials
60 19th of 34 higher than 15 of 34 other Cirrhosis, Liver trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cirrhosis, Liver trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Single and Multiple Dose Escalation of PHIN-214 in Child-Pugh A and B Liver Cirrhotics
RECRUITING · Phase 1
-
Comparison Between 2-dose Versus 3-dose Regimens of Heplisav B in Cirrhosis
RECRUITING · Phase 4
-
Measuring Patient Reported Needs in Outpatient Liver Disease Management
RECRUITING
-
Molecular Mechanism of Exercise in Cirrhosis
RECRUITING · NA
-
Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
RECRUITING · Phase 2
-
Development of 4D Flow MRI for Risk Stratification of Variceal Bleeding in Cirrhosis
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI